Status:
UNKNOWN
Effects of A Dual-Task Intervention in Postural Control in Multiple Sclerosis Patients
Lead Sponsor:
University Hospital, Limoges
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease affecting the central nervous system. It is the leading cause of severe non-traumatic disability in young adults (20-40 years). It ...
Eligibility Criteria
Inclusion
- patient aged 18 to 65 years old;
- relapsing-remitting MS (RR);
- able to hold the station standing 180s without a device assistance;
- Expanded Disability Status Scale \<4;
- able to give informed consent to participate in this study ;
- without any push in the 60 days before the participation in this study (to be clinically stable);
- no change in the treatment of MS since at least 2 month.
Exclusion
- acute illness other than MS during the past 60 days;
- neurological and psychiatric diseases, except the SEP ;
- orthopedic and rheumatological disorders that may affect the market ;
- visual acuity \<7/10 for the best eye after correction visual;
- patient undergoing psychiatric care;
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04090996
Start Date
January 20 2021
End Date
September 20 2022
Last Update
February 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurologie
Limoges, France